NCT03848806 - Efficacy and Safety of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque Psoriasis | Biotech Hunter

Enrollment

174

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 11, 2016

Study Completion Date

September 5, 2016

Conditions

Psoriasis

Interventions

DRUG

HAT1

During the treatment phase, patients will be ask to apply the product twice daily on all lesional areas. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.

DRUG

Calcipotriol

During the treatment phase, patients will be ask to apply the product twice daily on all lesional areas. The research team will provide instructions for the correct application of the treatment. If a lesion disappears, patients will continue applying the cream twice daily to the area. No additional creams, lotions or soaps other than provided test products will be allowed throughout the duration of the study.